Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma
出版年份 2022 全文链接
标题
Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma
作者
关键词
-
出版物
Frontiers in Oncology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-05-18
DOI
10.3389/fonc.2022.840241
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fibrotic Phenotype of Peritumour Mesenteric Adipose Tissue in Human Colon Cancer: A Potential Hallmark of Metastatic Properties
- (2021) Maria Tabuso et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
- (2021) Vincenzo Mattei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 40 Years of RAS—A Historic Overview
- (2021) Alberto Fernández-Medarde et al. Genes
- The Yin and Yang of Discoidin Domain Receptors (DDRs): Implications in Tumor Growth and Metastasis Development
- (2021) Sandra Majo et al. Cancers
- Consequences of Extracellular Matrix Remodeling in Headway and Metastasis of Cancer along with Novel Immunotherapies: A Great Promise for Future Endeavor
- (2021) Suman Kumar Ray et al. Anti-Cancer Agents in Medicinal Chemistry
- Infrequent RAS mutation is not associated with specific histological phenotype in gliomas
- (2021) Yasuhide Makino et al. BMC CANCER
- Brain and other central nervous system tumor statistics, 2021
- (2021) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Extracellular Matrix Biomarkers in Colorectal Cancer
- (2021) Min-Seob Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
- (2021) Ahmed Elkamhawy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Functional Characterization of Brain Tumor-Initiating Cells and Establishment of GBM Preclinical Models that Incorporate Heterogeneity, Therapy, and Sex Differences
- (2021) Cesar A. Garcia et al. MOLECULAR CANCER THERAPEUTICS
- Impact of proton therapy on antitumor immune response
- (2021) Céline Mirjolet et al. Scientific Reports
- NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
- (2021) Carolina Marques et al. eLife
- Epigenetic Regulation of the Wnt/β-Catenin Signaling Pathway in Cancer
- (2021) Ankita Sharma et al. Frontiers in Genetics
- EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
- (2021) Mary Luz Uribe et al. Cancers
- The SOX9-MMS22L Axis Promotes Oxaliplatin Resistance in Colorectal Cancer
- (2021) Yiqiang Liu et al. Frontiers in Molecular Biosciences
- Identifying Novel Actionable Targets in Colon Cancer
- (2021) Maria Grazia Cerrito et al. Biomedicines
- Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma
- (2021) Ilona Berestjuk et al. EMBO Molecular Medicine
- Targeting mutated GTPase KRAS in tumor therapies
- (2021) Guangjin Fan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- K-RAS Acts as a Critical Regulator of CD44 to Promote the Invasiveness and Stemness of GBM in Response to Ionizing Radiation
- (2021) Yi Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Meta-Analysis of Definitive Photon and Particle Irradiation for Locally Advanced Pancreatic Cancer
- (2021) D.K. Ebner et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
- (2021) J. Nathaniel Diehl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combination strategies to maximize the benefits of cancer immunotherapy
- (2021) Shaoming Zhu et al. Journal of Hematology & Oncology
- Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair
- (2021) Linlin Yang et al. NUCLEIC ACIDS RESEARCH
- Oncogenic KRAS: Signaling and Drug Resistance
- (2021) Hyeon Jin Kim et al. Cancers
- Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer
- (2021) Li Chen et al. Frontiers in Cell and Developmental Biology
- Wnt/beta-catenin and PI3K/Akt/mtor Signaling Pathways in Glioblastoma: Two main targets for drug design: A Review
- (2020) Seyed Hossein Shahcheraghi et al. CURRENT PHARMACEUTICAL DESIGN
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
- (2020) Jenny Y. Xue et al. NATURE
- Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer
- (2020) Marie Lafitte et al. Frontiers in Oncology
- Discoidin Domain Receptor 1 (DDR1) is Necessary for Tissue Homeostasis in Pancreatic Injury and Pathogenesis of Pancreatic Ductal Adenocarcinoma
- (2020) Jeanine M. Ruggeri et al. AMERICAN JOURNAL OF PATHOLOGY
- Direct KRAS inhibition: progress, challenges, and a glimpse into the future
- (2020) Dimitra Grapsa et al. Expert Review of Anticancer Therapy
- A perspective on the early days of RAS research
- (2020) Robin A. Weiss CANCER AND METASTASIS REVIEWS
- Pilot study of neurologic toxicity in mice after proton minibeam therapy
- (2020) John G. Eley et al. Scientific Reports
- Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges
- (2020) Joyce Y. Buikhuisen et al. Oncogenesis
- The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma
- (2020) Plabon Kumar Das et al. Cells
- CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
- (2020) María Auxiliadora Olivares-Urbano et al. Cells
- BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
- (2020) Zi-Nan Li et al. Gastroenterology Report
- Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma
- (2020) Marie-Julie Nokin et al. JCI Insight
- Novel regulation of Ras proteins by direct tyrosine phosphorylation and dephosphorylation
- (2020) László Buday et al. CANCER AND METASTASIS REVIEWS
- In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance
- (2020) Chi Chun Wong et al. GASTROENTEROLOGY
- Concepts of extracellular matrix remodelling in tumour progression and metastasis
- (2020) Juliane Winkler et al. Nature Communications
- A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma
- (2020) Bin Sheng Wong et al. Nature Biomedical Engineering
- MEK inhibitor resistance mechanisms and recent developments in combination trials
- (2020) E. Kun et al. CANCER TREATMENT REVIEWS
- PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells
- (2020) Zhangsen Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the Wnt/β-catenin signaling pathway in cancer
- (2020) Ya Zhang et al. Journal of Hematology & Oncology
- The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness
- (2020) Johanna Grinat et al. Nature Communications
- Interaction of Discoidin Domain Receptor 1 with a 14-3-3-Beclin-1-Akt1 Complex Modulates Glioblastoma Therapy Sensitivity
- (2019) Anne Vehlow et al. Cell Reports
- The role of SOX family members in solid tumours and metastasis
- (2019) Daniela Grimm et al. SEMINARS IN CANCER BIOLOGY
- Treatment sequencing in metastatic colorectal cancer
- (2019) D.P. Modest et al. EUROPEAN JOURNAL OF CANCER
- The landscape of the mesenchymal signature in brain tumours
- (2019) Jinan Behnan et al. BRAIN
- A structural prospective for collagen receptors such as DDR and their binding of the collagen fibril
- (2019) Joseph P.R.O. Orgel et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
- (2019) Suhas Vasaikar et al. CELL
- RAS mutations in human cancers: Roles in precision medicine
- (2019) Avaniyapuram Kannan Murugan et al. SEMINARS IN CANCER BIOLOGY
- Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
- (2019) NaNa Keum et al. Nature Reviews Gastroenterology & Hepatology
- RAS: Striking at the Core of the Oncogenic Circuitry
- (2019) Ryan C. Gimple et al. Frontiers in Oncology
- A mutant KRAS‐induced factor REG4 promotes cancer stem cell properties via Wnt/β‐catenin signaling
- (2019) Jeong‐Ha Hwang et al. INTERNATIONAL JOURNAL OF CANCER
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
- (2019) Salo N. Ooft et al. Science Translational Medicine
- Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients
- (2019) Steven M. Bray et al. Scientific Reports
- Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3
- (2018) Jeffrey S. Ross et al. CANCER
- Combination Therapy and the Evolution of Resistance: The Theoretical Merits of Synergism and Antagonism in Cancer
- (2018) Elysia C. Saputra et al. CANCER RESEARCH
- Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
- (2018) Maya Jeitany et al. EMBO Molecular Medicine
- Emerging therapeutic targets for neurofibromatosis type 1
- (2018) James A. Walker et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice
- (2018) Xiujie Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemotherapeutic drug delivery by tumoral extracellular matrix targeting
- (2018) René Raavé et al. JOURNAL OF CONTROLLED RELEASE
- Biomechanical and biomolecular characterization of extracellular matrix structures in human colon carcinomas
- (2018) Eva Brauchle et al. MATRIX BIOLOGY
- COL1A1 promotes metastasis in colorectal cancer by regulating the WNT/PCP pathway
- (2018) Zheying Zhang et al. Molecular Medicine Reports
- Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
- (2018) Dietrich A. Ruess et al. NATURE MEDICINE
- Targeting the RAS-dependent chemoresistance: The Warburg connection
- (2018) Roberto Serna-Blasco et al. SEMINARS IN CANCER BIOLOGY
- Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
- (2018) Sigrid A. Langhans Frontiers in Pharmacology
- COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS
- (2018) Zheying Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cellular and molecular mechanisms underlying planar cell polarity pathway contributions to cancer malignancy
- (2018) Kacey VanderVorst et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models
- (2018) Carmine Fedele et al. Cancer Discovery
- R-spodin2 enhances canonical Wnt signaling to maintain the stemness of glioblastoma cells
- (2018) Si Liu et al. Cancer Cell International
- RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling
- (2018) Zhan Yao et al. NATURE MEDICINE
- Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
- (2018) Xiaofei Cheng et al. BIOMEDICINE & PHARMACOTHERAPY
- The dose-dependent effect of SOX9 and its incidence in colorectal cancer
- (2017) Corinne Prévostel et al. EUROPEAN JOURNAL OF CANCER
- Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling
- (2017) Georg Emons et al. MOLECULAR CANCER RESEARCH
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer
- (2017) Kristen K. Ciombor et al. ONCOLOGIST
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- A Computational Approach for Identifying Synergistic Drug Combinations
- (2017) Kaitlyn M. Gayvert et al. PLoS Computational Biology
- RAS isoforms and mutations in cancer at a glance
- (2016) G. Aaron Hobbs et al. JOURNAL OF CELL SCIENCE
- Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
- (2016) Chiara Ambrogio et al. NATURE MEDICINE
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Potential role of Wnt/β-catenin signaling in blastic transformation of chronic myeloid leukemia: cross talk between β-catenin and BCR-ABL
- (2016) Jing Hu et al. TUMOR BIOLOGY
- Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models
- (2016) Zsófia Sztupinszki et al. Scientific Reports
- Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients
- (2016) S. N. Kehlet et al. Scientific Reports
- A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†
- (2015) G. R. Blumenschein et al. ANNALS OF ONCOLOGY
- A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies
- (2015) John F. Deeken et al. CANCER
- SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling
- (2015) Hongwei Liu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding
- (2015) Pamela Y. Ting et al. FASEB JOURNAL
- The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
- (2015) Enzo Medico et al. Nature Communications
- Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
- (2015) Timothy J. Stuhlmiller et al. Cell Reports
- Colorectal cancer
- (2015) Ernst J. Kuipers et al. Nature Reviews Disease Primers
- Constitutive Activation of Raf-1 Induces Glioma Formation in Mice
- (2015) Yelena Lyustikman et al. NEOPLASIA
- The predictive value ofKRAS, NRAS, BRAF, PIK3CAand PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
- (2014) Christina Therkildsen et al. ACTA ONCOLOGICA
- Preoperative chemoradiotherapy in rectal cancer induces changes in the expression of nuclear β-catenin: prognostic significance
- (2014) Jaime Gomez-Millan et al. BMC CANCER
- Vangl1 and Vangl2: planar cell polarity components with a developing role in cancer
- (2014) J. Hatakeyama et al. ENDOCRINE-RELATED CANCER
- Structural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase Inhibitors
- (2014) Peter Canning et al. JOURNAL OF MOLECULAR BIOLOGY
- Role of Oncogenic K-Ras in Cancer Stem Cell Activation by Aberrant Wnt/β-Catenin Signaling
- (2014) Byoung-San Moon et al. JNCI-Journal of the National Cancer Institute
- Mutations in Specific Codons of the KRAS Oncogene are Associated with Variable Resistance to Neoadjuvant Chemoradiation Therapy in Patients with Rectal Adenocarcinoma
- (2013) Marjun P. Duldulao et al. ANNALS OF SURGICAL ONCOLOGY
- KRAS Mutations and Rectal Cancer Response to Chemoradiation: Are We Closer to Personalization of Therapy?
- (2013) Sunil Krishnan et al. ANNALS OF SURGICAL ONCOLOGY
- Mechanisms of RAS/β-catenin interactions
- (2013) Eva Zeller et al. ARCHIVES OF TOXICOLOGY
- Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN
- (2013) X.-R. Wang et al. NEURO-ONCOLOGY
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells
- (2009) S C Kirkland BRITISH JOURNAL OF CANCER
- Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
- (2009) David Z Chang et al. Journal of Hematology & Oncology
- Mechanisms of drug combinations: interaction and network perspectives
- (2009) Jia Jia et al. NATURE REVIEWS DRUG DISCOVERY
- Proteomic, functional and motif-based analysis of C-terminal Src kinase-interacting proteins
- (2009) Guang Yang et al. PROTEOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started